Milesight AT101 is an exceptional outdoor tracker that combines GNSS and Wi-Fi AP MAC Address Scanning technologies to deliver highly accurate positioning data. It is equipped with tilt and temperature sensors, enabling extensive data collection and versatile application in various scenarios.
Given the promising preclinical results, we tested the clinical h1218-CART19 product (AT101) in a first-in-human, multi-center, phase I/II, dose-escalation clinical trial for pts with histologically confirmed relapsed or refractory B cell NHL (NCT05338931).
A First-in-Human Phase I Study of AT101, a Novel Anti-CD19 Chimeric ...
An Open-label, Single-arm, Multi-center, Phase I/II Study to Evaluate the Safety, Tolerability, and Efficacy of AT101 (Anti-CD19 Chimeric Antigen Receptor T Cell) in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma.
Engineered for precision and performance, this specialized tire ensures unparalleled control and grip, allowing you to maintain your lawn effortlessly. With its muted lug depth, the AT101 strikes the perfect balance between traction and maneuverability, preventing slipping on wet or uneven surfaces.
A phase 1 study of AT101, a novel anti-CD19 CAR-T cell therapy targeting a membrane-proximal epitope of CD19, in patients with relapsed or refractory B cell non-Hodgkin lymphoma.
A phase 1 study of AT101, a novel anti-CD19 CAR-T cell therapy ...
Milesight AT101 LoRa GPS Tracker is an exceptional outdoor tracker that combines GNSS and Wi-Fi AP MAC Address Scanning technologies to deliver highly accurate positioning data.
AT101 is an advanced CAR-T therapy targeting CD19-expressing hematologic cancers with superior efficacy compared to conventional treatments using a unique humanized antibody.
AT101 is an advanced biopharmaceutical candidate currently under development for patients with B-cell lymphoma (BCL) who have relapsed or failed to respond to existing treatments.